Steven W. Andrews

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

Aria Vaishnavi, Marzia Capelletti, Anh T. Le et al. · Nature Medicine · 2013 · 602 citations · Full text

Medicine, Molecular Biology, Oncology +12

Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)

Scott D. Seiwert, Steven W. Andrews, Yutong Jiang et al. · Antimicrobial Agents and Chemotherapy · 2008 · 174 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024)

David F. Woodward, Achim H.‐P. Krauss, J. Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 146 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease

Yutong Jiang, Steven W. Andrews, Kevin R. Condroski et al. · Journal of Medicinal Chemistry · 2013 · 142 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Colonization of the Human Oral Cavity by a Streptococcus mutans Mutant Producing Increased Bacteriocin

J.D. Hillman, A.L. Dzuback, Steven W. Andrews · Journal of Dental Research · 1987 · 103 citations

Dentistry, Microbiology, Oral Biology +17